MIR9-2HG and neoplasm: Knockdown of LINC00461 suppressed glioma cell proliferation, migration, invasion, and TMZ resistance in U251 and A172 cells in vitro and inhibited tumor growth in vivo through targeting miR-216a and downregulating AQP4.